| Term 
 | Definition 
 
        | Works to dec. insulin output and inc the muscular sensitivity to insulin. 500 mg DID or 850 mg once a day
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Drug of choice for T2DM, Many contraindications. Adv: No Hypoglycemia or weight gain
 Dis: Gi discomfort (take in slow dose), tastes like metal.
 Works on liver to dec. glucose output and on muscles to inc. insulin sensitivity.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Thiazolidinedione 15 or 30 mg once daily.
 Primarily inc. muscle sensitivity and secondary dec. glucose output.
 Adv: no hypoglycemia and fav lipid effects.
 Dis: adema and fluid retention, weight gain, heart failure, osteopenia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 5 mg once a day. Sulfonylurea: Incretin mimetic, stimulates the pancreas to release insulin.
 Dis: hypoglycemia, weight gain
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | .5-2 mg before the meal Glinide: Incretin mimetic (stimulate pancreas to release insulin).
 Dis: weight gain, hypoglycemia (slight)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alpha-Glucosidase Inhibitor Delays carbohydrate absorption in small intestine (type II)
 Dis: GI problems (gas, bloating, diarrhea).
 Do not use oral sucrose.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Incretin Mimetic 5 mcg subqutaniously twice a day
 Found in Gila Monster
 Limits food intake and gastric emptying as well as postprandial glucagon if inappropriate.
 Dis: Nausea, hypoglycemia, slows the extent and rate of absorption of other meds (meds taken 1 hour before exenatide)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Incretin Mimetic Limits food intake, gastric emptying and postprandial glucagon.
 Adv: weight loss
 Dis: Nausea, hypoglycemia, slows the extent and rate of absorption of other meds (meds taken 1 hour before exenatide)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | DPP-4 Inhibitor 100 mg by mouth once daily
 Adv: No hypoglycemia
 Dis: hypersensitivity, placebo esq, Nasopharyngitis, upper respiratory infection
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Amylinomimetric SubQ
 Mimics Amylin which is secreted with insulin
 Adv: weight loss, lower risk of hypoglycemia
 Dis: severe hypoglycemia, nausea, vomiting, Meds need to be taken 1 hour before
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 6 tablets once daily Unknown Mechanism
 Adv: no hypoglycemia, favorable effects on lipis
 Dis: may contraindications, constipation, many drug interactions (drugs should be admin 4 hours before taking this)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Basal Insulin Peak 4-10 hours, duration 10-16 hours
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Basal Insulin Peak: 6-8 Hours, duration: 6-23 hours
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Basal Insulin Peak: NONE, Duration: 24 Hours
 |  | 
        |  |